Biopsy image-based deep learning for predicting pathologic response to neoadjuvant chemotherapy in patients with NSCLC
Abstract Neoadjuvant chemotherapy (NAC) is a widely used therapeutic strategy for patients with resectable non-small cell lung cancer (NSCLC). However, individual responses to NAC vary widely among patients, limiting its effective clinical application. In this study, we propose a weakly supervised d...
Saved in:
| Main Authors: | Yibo Zhang, Shuaibo Wang, Xinying Liu, Yang Qu, Zijian Yang, Yang Su, Bin Hu, Yousheng Mao, Dongmei Lin, Lin Yang, Meng Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-025-00927-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Accuracy of core biopsy image-guided post-neoadjuvant chemotherapy breast to predict pathologic complete response
by: P. V. Krivorotko, et al.
Published: (2022-12-01) -
Pathological mechanisms and advances in neoadjuvant PD-1 blockade combined with chemotherapy for head and neck cancer
by: Yun-jing Hou, et al.
Published: (2024-12-01) -
NeoPred: dual-phase CT AI forecasts pathologic response to neoadjuvant chemo-immunotherapy in NSCLC
by: Rui Wang, et al.
Published: (2025-05-01) -
Navigating the landscape of neoadjuvant immunotherapy for NSCLC: progress and controversies
by: Yuzhu Chen, et al.
Published: (2025-01-01) -
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis
by: Yanxiong Mao, et al.
Published: (2024-11-01)